In the current study, we showed that 5-azacytidine epigenetic priming improved platinum-based salvage chemotherapy in DLBCL via ERV-induced cGAS-STING activation rather than via dsRNA sensor activation. This evidence concerns the gene CGAS and diffuse large B-cell lymphoma.